<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02318173</url>
  </required_header>
  <id_info>
    <org_study_id>DIS-2014-009</org_study_id>
    <nct_id>NCT02318173</nct_id>
  </id_info>
  <brief_title>Dilapan-S/Dilasoft E-Registry in Induction of Labor</brief_title>
  <acronym>DSREGISTRYIL</acronym>
  <official_title>International Observational E-Registry on the Use of Dilapan-S / Dilasoft Osmotic Dilators for Cervical Ripening Prior to Labour Induction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medicem International CR s.r.o.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medicem International CR s.r.o.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      International Observational E-Registry on the use of DILAPAN-S® osmotic dilator / DILASOFT®
      osmotic dilator for cervical ripening prior to labour induction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      International Observational E-Registry to monitor current common clinical practice of use of
      Dilapan-S / Dilasoft for cervical ripening and following procedures of labour induction with
      the main focus on the duration of induced labor procedure .
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2015</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of Dilapan-S/Dilasoft insertion</measure>
    <time_frame>max. up to 24 hrs; estimated average 12 hrs)</time_frame>
    <description>duration of cervical ripening</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Induction - delivery interval</measure>
    <time_frame>estimated maximum up to 72 hrs</time_frame>
    <description>Overall duration of induced labor procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of vaginal deliveries within 24 hours</measure>
    <time_frame>up to 24 hrs</time_frame>
    <description>Rate of vaginal deliveries achieved within 24 hours from the beginning of induced labor procedure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Type of osmotic dilator used: Dilapan-S or Dilasoft</measure>
    <time_frame>up to 24 hrs; estimated average 12 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of dilators inserted</measure>
    <time_frame>up to 24 hrs; estimated average 12 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bishop Score increase after extraction of osmotic dilators</measure>
    <time_frame>up to 24 hrs; estimated average 12 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications during pre-induction</measure>
    <time_frame>up to 24 hrs; estimated average 12 hrs</time_frame>
    <description>uterine contractions, uterine hypersensitivity, effect on the foetus</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Agents / procedures used for induction of labour, if any</measure>
    <time_frame>estimated maximum up to 72 hrs</time_frame>
    <description>which, total dosage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of spontaneous vaginal deliveries following immediately after pre-induction</measure>
    <time_frame>up to 24 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of total spontaneous vaginal deliveries</measure>
    <time_frame>estimated maximum up to 72 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of instrumented vaginal deliveries</measure>
    <time_frame>estimated maximum up to 72 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>% of Caesarean sections</measure>
    <time_frame>estimated maximum up to 72 hrs</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Foetal status</measure>
    <time_frame>0, 5 and 10 minutes after delivery (estimated maximum up to 72 hrs)</time_frame>
    <description>Apgar score at 0, 5 and 10 minutes after delivery, venous and arterial cord pH and base excess measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maternal infectious complication and its relation to the use of Dilapan-S/Dilasoft</measure>
    <time_frame>up to 72 hrs; Complications, if any, will be followed-up until stable situation has been reached.</time_frame>
    <description>Clinical signs of maternal infection found at patient´s examination are defined as follows:
Body temperature &gt; 37.8°C
Increased pain
Other overt clinical signs of infection e.g. vaginal discharge
Laboratory test results that need to be correlated with clinical signs of infection:
CRP levels &gt; 8 mg/l
Leukocyte count &gt; 18 x 109/l
Positive microbiological testing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal infectious complication and its relation to the use of Dilapan-S/Dilasoft</measure>
    <time_frame>up to 72 hrs; Complications, if any, will be followed-up until stable situation has been reached.</time_frame>
    <description>Clinical signs of neonatal infection found at patient´s examination are defined as follows:
Body temperature &gt; 37.8°C
Increased pain
Other overt clinical signs of infection e.g. vaginal discharge
Laboratory test results that need to be correlated with clinical signs of infection:
CRP levels &gt; 8 mg/l
Leukocyte count &gt; 18 x 109/l
Positive microbiological testing</description>
  </secondary_outcome>
  <enrollment type="Actual">444</enrollment>
  <condition>Labour Onset and Length Abnormalities</condition>
  <condition>Labor; Forced or Induced, Affecting Fetus or Newborn</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilapan-S</intervention_name>
    <description>Synthetic osmotic dilators Dilapan-S, Dilasoft for cervical ripening prior to induction of labor in women with unfavourable cervix</description>
    <other_name>Dilasoft</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All the patients in whom the use of osmotic dilators Dilapan-S or Dilasoft is indicated by
        the Investigator after a thorough Medical examination will be included in the study unless
        that the patient disagree.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Indication for induction of labor

          -  Unfavourable cervix

        Exclusion Criteria:

          -  Presence of overt genital tract infection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Hellmeyer, Doz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vivantes Klinikum im Friedrichshain, Berlin, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Franz Bahlman, Doz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Buerger Hospital, Frankfurt am Main, Germany</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Janesh Gupta, MD, FRCOG</last_name>
    <role>Study Chair</role>
    <affiliation>Birmingham Women´s Hospital, Birmingham, UK</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Petr Janku, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Masaryk University Hospital, Brno, Czech Republic</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jozef Zahumensky, Doc, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Trnava, Slovakia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Oleg Baev, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal State Budget Institution &quot;Research Center for Obstetrics, Gynecology and Perinatology&quot; of the Ministry of Healthcare of Russian Federation, Moscow, RUS</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Saad, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Texas Medical Branch Galveston, TX, US</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amitasrigowri Murthy, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bellevue Hospital, New York City, NY, US</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amita Suneja, Prof, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guru Teg Bahadur Hospital, New Delhi, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Usha Vishwanath, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sri Ramachandra Medical Center, Chennai, India</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anisha Gala, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fernandez Hospital, Hyderabad, India</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bellevue Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Medical Branch Galveston</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Masaryk University</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vivantes Klinikum im Friedrichshain</name>
      <address>
        <city>Berlin</city>
        <zip>10249</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Buerger Hospital</name>
      <address>
        <city>Frankfurt am Main</city>
        <zip>60318</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guru Teg Bahadur Hospital</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110095</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sri Ramachandra Medical Center</name>
      <address>
        <city>Chennai</city>
        <state>Tamil Nadu</state>
        <zip>600116</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fernandez Hospital</name>
      <address>
        <city>Hyderabad</city>
        <state>Telangana</state>
        <zip>500001</zip>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Federal State Budget Institution &quot;Research Center for Obstetrics, Gynecology and Perinatology&quot; of the Ministry of Healthcare of Russian Federation</name>
      <address>
        <city>Moscow</city>
        <zip>117997</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Trnava</name>
      <address>
        <city>Trnava</city>
        <zip>917 75</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Women´s Hospital</name>
      <address>
        <city>Birmingham</city>
        <state>West Midlands</state>
        <zip>B15 2TG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Germany</country>
    <country>India</country>
    <country>Russian Federation</country>
    <country>Slovakia</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <reference>
    <citation>Sanchez-Ramos L. Induction of labor. Obstet Gynecol Clin North Am. 2005 Jun;32(2):181-200, viii. Review.</citation>
    <PMID>15899354</PMID>
  </reference>
  <reference>
    <citation>Tenore JL. Methods for cervical ripening and induction of labor. Am Fam Physician. 2003 May 15;67(10):2123-8. Review.</citation>
    <PMID>12776961</PMID>
  </reference>
  <reference>
    <citation>Ten Eikelder ML, Neervoort F, Oude Rengerink K, van Baaren GJ, Jozwiak M, de Leeuw JW, de Graaf I, van Pampus MG, Franssen M, Oudijk M, van der Salm P, Woiski M, Pernet PJ, Feitsma AH, van Vliet H, Porath M, Roumen F, van Beek E, Versendaal H, Heres M, Mol BW, Bloemenkamp KW. Induction of labour with a Foley catheter or oral misoprostol at term: the PROBAAT-II study, a multicentre randomised controlled trial. BMC Pregnancy Childbirth. 2013 Mar 19;13:67. doi: 10.1186/1471-2393-13-67. Erratum in: BMC Pregnancy Childbirth. 2013;13:183. van Baaren, Gert J [added].</citation>
    <PMID>23506128</PMID>
  </reference>
  <reference>
    <citation>Jozwiak M, ten Eikelder M, Oude Rengerink K, de Groot C, Feitsma H, Spaanderman M, van Pampus M, de Leeuw JW, Mol BW, Bloemenkamp K; PROBAAT Study Group. Foley catheter versus vaginal misoprostol: randomized controlled trial (PROBAAT-M study) and systematic review and meta-analysis of literature. Am J Perinatol. 2014 Feb;31(2):145-56. doi: 10.1055/s-0033-1341573. Epub 2013 Apr 5.</citation>
    <PMID>23564065</PMID>
  </reference>
  <reference>
    <citation>Sciscione AC, McCullough H, Manley JS, Shlossman PA, Pollock M, Colmorgen GH. A prospective, randomized comparison of Foley catheter insertion versus intracervical prostaglandin E2 gel for preinduction cervical ripening. Am J Obstet Gynecol. 1999 Jan;180(1 Pt 1):55-60.</citation>
    <PMID>9914578</PMID>
  </reference>
  <reference>
    <citation>Cromi A, Ghezzi F, Uccella S, Agosti M, Serati M, Marchitelli G, Bolis P. A randomized trial of preinduction cervical ripening: dinoprostone vaginal insert versus double-balloon catheter. Am J Obstet Gynecol. 2012 Aug;207(2):125.e1-7. doi: 10.1016/j.ajog.2012.05.020. Epub 2012 Jun 1.</citation>
    <PMID>22704766</PMID>
  </reference>
  <reference>
    <citation>Suffecool K, Rosenn BM, Kam S, Mushi J, Foroutan J, Herrera K. Labor induction in nulliparous women with an unfavorable cervix: double balloon catheter versus dinoprostone. J Perinat Med. 2014 Mar;42(2):213-8. doi: 10.1515/jpm-2013-0152.</citation>
    <PMID>24096438</PMID>
  </reference>
  <reference>
    <citation>Lichtenberg ES. Complications of osmotic dilators. Obstet Gynecol Surv. 2004 Jul;59(7):528-36. Review.</citation>
    <PMID>15199271</PMID>
  </reference>
  <reference>
    <citation>Chua S, Arulkumaran S, Vanaja K, Ratnam SS. Preinduction cervical ripening: prostaglandin E2 gel vs hygroscopic mechanical dilator. J Obstet Gynaecol Res. 1997 Apr;23(2):171-7.</citation>
    <PMID>9158305</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 9, 2014</study_first_submitted>
  <study_first_submitted_qc>December 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2014</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cervical dilatation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

